Michael Gnant , FACS, EBSQhon
Corresponding Member of the Division of Mathematics and Natural Sciences in Austria since 2017
- Comprehensive Cancer Center, Medizinische Universität Wien
Contact:
michael.gnant(at)meduniwien.ac.at
Orcid-ID:
0000-0003-1002-2118
Research Areas:
- Clinical Medicine
- Cancer research
- Experimental surgery
- Brustkrebs
- Klinische Studien
Profile:
Selected Memberships:
- American College of Surgeons
- American Society of Clinical Oncology
- American Society of Cancer Research
- Breast International Group
- Österreichische Gesellschaft für Chirurgische Onkologie
- St. Gallen International Breast Cancer Conference
- European Organisation for Research and Treatment of Cancer
Selected Prizes:
- Umberto Veronesi Award von Breast Surgery International
- Claudia von Schilling Preis der Medizinischen Hochschule Hannover
- Theodor-Billroth-Preis der Ärztekammer für Wien (2x)
- Martin Research Prize of the Massachusetts General Hospital (Harvard University)
- Großer Zentaleuropäischer Preise der Stadt Wien für Interdisziplinäre Krebsforschung
Selected Publications:
- Gnant, Michael et. al (2022) Long-Term Outcomes of Adjuvant Denosumab in Breast Cancer, New England Journal of Medicine Evidence, Bd. 1.
- Gnant M, et al. Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer. N Engl J Med. 2021 Jul 29;385(5):395-405.
- Gnant, Michael; Harbeck, Nadia (2017, online: 2016) Breast Cancer. Lancet, Bd. 389 (10074), S. 1134-1150.
- Gnant, Michael et al. (2015) Adjuvant denosumab in breast cancer - a multicentre, randomised, double-blind, placebo-controlled trial (ABCSG-18). Lancet, Bd. 386 (9992), S. 433-443.
- GnantM et al. Endocrine therapy plus zoledronic acid in premenopausal breast cancer. N Engl J Med. 2009 Feb 12;360(7):679-91.